Immunomodulation in Oncolytic Measles Virotherapy
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-9794-7_7
Reference60 articles.
1. Bluming AZ, Ziegler JL (1971) Regression of Burkitt’s lymphoma in association with measles infection. Lancet 2(7715):105–106
2. Mota HC (1973) Infantile Hodgkin’s disease: remission after measles. Br Med J 2(5863):421
3. Russell SJ, Peng KW (2009) Measles virus for cancer therapy. Curr Top Microbiol Immunol 330:213–241
4. Robinson S, Galanis E (2017) Potential and clinical translation of oncolytic measles viruses. Expert Opin Biol Ther 17(3):353–363. https://doi.org/10.1080/14712598.2017.1288713
5. Shingai M, Ebihara T, Begum NA, Kato A, Honma T, Matsumoto K, Saito H, Ogura H, Matsumoto M, Seya T (2007) Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 179(9):6123–6133
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis;Cell Death Discovery;2023-05-19
2. Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection;Journal of Medical Virology;2023-04
3. Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model;Frontiers in Immunology;2023-01-16
4. Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment;Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs);2023
5. Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine;Molecular Therapy - Methods & Clinical Development;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3